Bridgewater Bancshares Inc·4

Apr 17, 4:55 PM ET

Crocker Mary Jayne 4

4 · Bridgewater Bancshares Inc · Filed Apr 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Bridgewater (BWB) Director Mary Jayne Crocker Exercises Options

What Happened
Mary Jayne Crocker, a director of Bridgewater Bancshares Inc. (BWB), exercised stock options on 2026-04-16 to acquire 6,750 common shares at an exercise price of $12.92 per share, for a total cash outlay of $87,210. The Form 4 also reports the conversion/disposition of 6,750 derivative units at $0.00 — a routine reporting line that reflects the option being surrendered/converted upon exercise. No cash sale of the acquired shares was reported in this filing.

Key Details

  • Transaction date: 2026-04-16 (Form filed 2026-04-17; timely filing).
  • Exercise: 6,750 shares acquired at $12.92 per share = $87,210 total (transaction code M = option exercise).
  • Derivative disposition: 6,750 units reported disposed at $0.00 (reflects conversion/cancellation of the option).
  • Shares owned after transaction: Not shown in the provided excerpt of the filing.
  • Footnotes: Options granted under the 2017 Combined Incentive and Non‑Statutory Stock Option Plan (F1). Vesting schedules cited in the filing include grants with vesting in 25% annual increments (grant dates 12/6/2019 and 2/1/2022) and a grant with 20% annual vesting (grant date 10/1/2017) (F2–F4).
  • Filing timeliness: Filed the day after the transaction (appears timely).

Context
This was an exercise of previously granted options (a purchase/acquisition of shares), not an open‑market purchase or a sale. For retail investors, option exercises are often routine (vesting or planned exercises) but do increase the insider’s direct share ownership. The $0.00 derivative line is a standard way filings show the option instrument was disposed of upon exercise and does not indicate a separate cash sale.

Insider Transaction Report

Form 4
Period: 2026-04-16
Transactions
  • Exercise/Conversion

    Common Stock

    2026-04-16$12.92/sh+6,750$87,210216,027 total
  • Exercise/Conversion

    Option to buy

    [F1][F2]
    2026-04-166,75020,250 total
    Exercise: $12.92Exp: 2029-12-06Common Stock (6,750 underlying)
Holdings
  • Option to buy

    [F1][F3]
    Exercise: $7.47Exp: 2027-09-30Common Stock (91,102 underlying)
    91,102
  • Option to buy

    [F1][F4]
    Exercise: $17.50Exp: 2032-02-01Common Stock (20,000 underlying)
    20,000
Footnotes (4)
  • [F1]Options to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Option Plan.
  • [F2]Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 12/6/2019.
  • [F3]Options exercisable in 20% increments on the first five anniversaries of the date of the grant which was 10/1/2017.
  • [F4]Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 2/1/2022.
Signature
/s/ Ben Klocke, Attorney-in-Fact|2026-04-17

Documents

1 file
  • 4
    form4-04172026_080432.xmlPrimary